Diagnosis and Natural History of Pulmonary Infections in Transplant Recipients
Year: 2000
Type: editorial
Abstract: Over the past 20 years, opportunistic lung infections have become a serious clinical problem for solid organ and bone marrow transplant (BMT) recipients, because of their immunosuppressive therapy intended to prevent allograft rejection. Without prophylactic antimicrobial therapy, transplant recipients may suffer life-threatening pulmonary infections, including Pneumocystis carinii pneumonia (PCP) and cytomegalovirus (CMV) pneumonitis. With the advent of newer immunosuppressive agents, like mycophenolate mofetil, tacrolimus, and rapamycin, the nature of immunosuppression and the accompanying susceptibility to opportunistic infection have continued to evolve.
Source: CHEST Journal
Authors: Norman W. Rizk, John L. Faul
Institution: Stanford Medicine
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,160
OpenAlex ID: W2033548993
